LC-HRMS Analysis of E-Liquids and Vaping-Induced Cytotoxicity
Year: 2026
Type: article
Abstract: Vaping has emerged as a common alternative to cigarette smoking, yet increasing evidence demonstrates its potential to induce oxidative stress, inflammation, and, importantly, cytotoxicity. A major characteristic of vaping material, i.e., e-liquid, is its unique and variable chemical composition. We conjectured that unique e-liquids would exhibit variable cytotoxic potential, with different cell types also likely displaying disparate cytotoxic characteristics. To test this hypothesis, commercially available e-liquids were vaped, recondensed, and then chemically characterized by LC-HRMS. Multiple cell types (human embryonic kidney 293 (HEK293), lung adenocarcinoma (A549), glioblastoma (DBTRG-05MG), and monocytic (THP-1)) were exposed to these vaped e-liquid condensates (1–5%) for 24 h. Viability assays were then performed. While the HEK293 and THP-1 cells were sensitive to e-liquid-induced cytotoxicity, the A549 and DBTRG-05MG cells were relatively more resistant. Overall, the reported findings support that vaping-induced cytotoxicity is indeed dose-dependent and dependent upon both the unique e-liquid being utilized and the cell type being assessed. In conclusion, this study indicates the continued importance of characterizing e-liquids as a potential assessment point of e-cigarette-induced cytotoxicity.
Source: Toxics
Authors: Destiny Gamble(Conceptualization, Formal analysis, Methodology, Writing – original draft), Imari Walker-Franklin(Data curation, Formal analysis, Investigation, Methodology, Writing – review & editing), Alex Kovach(Formal analysis, Investigation, Methodology, Writing – review & editing), Rob U. Onyenwoke(Conceptualization, Data curation, Formal analysis, Funding acquisition, Methodology, Project administration, Resources, Supervision, Writing – original draft, Writing – review & editing)
Institutions: North Carolina Central University, RTI International
Language: English
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $3,137
OpenAlex ID: W7235583377
